tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

URGN Stock Latest News

UroGen Pharma reports ENVISION results to be published in The Journal of Urology
The FlyUroGen Pharma reports ENVISION results to be published in The Journal of Urology
4d ago
URGN
UroGen Pharma Highlights RTGel® Platform and Growth Plans
PremiumCompany Announcements
UroGen Pharma Highlights RTGel® Platform and Growth Plans
5d ago
8K
URGN
UroGen Pharma presents long-term, follow-up Jelmyto study data
PremiumThe Fly
UroGen Pharma presents long-term, follow-up Jelmyto study data
1M ago
URGN
UroGen Pharma: UGN-102 showed ‘promising’ results in Phase 3 Envision trial
PremiumThe Fly
UroGen Pharma: UGN-102 showed ‘promising’ results in Phase 3 Envision trial
1M ago
URGN
UroGen Pharma publishes long-term Jelmyto follow-up study results
PremiumThe Fly
UroGen Pharma publishes long-term Jelmyto follow-up study results
2M ago
URGN
UroGen Pharma Reports Q3 Results and Drug Progress
PremiumCompany AnnouncementsUroGen Pharma Reports Q3 Results and Drug Progress
2M ago
URGN
UroGen Pharma reports Q3 EPS (55c), consensus (82c)
Premium
The Fly
UroGen Pharma reports Q3 EPS (55c), consensus (82c)
2M ago
URGN
UroGen Pharma price target raised to $64 from $60 at H.C. Wainwright
Premium
The Fly
UroGen Pharma price target raised to $64 from $60 at H.C. Wainwright
3M ago
URGN
UroGen Pharma announces FDA acceptance of new drug application for UGN-102
PremiumThe Fly
UroGen Pharma announces FDA acceptance of new drug application for UGN-102
3M ago
URGN
UroGen Pharma initiated with a Buy at EF Hutton
PremiumThe Fly
UroGen Pharma initiated with a Buy at EF Hutton
3M ago
URGN
UroGen Pharma Announces CFO Transition and Compensation Details
PremiumCompany Announcements
UroGen Pharma Announces CFO Transition and Compensation Details
3M ago
8K
URGN
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
PremiumThe Fly
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
3M ago
GRTX
URGN
UroGen Pharma: Patient dosed in mitomycin-based UGN-103 trial for LG-IR-NMIBC
PremiumThe FlyUroGen Pharma: Patient dosed in mitomycin-based UGN-103 trial for LG-IR-NMIBC
4M ago
URGN
UroGen Pharma receives new U.S. patent allowance for RTGel technology
Premium
The Fly
UroGen Pharma receives new U.S. patent allowance for RTGel technology
4M ago
URGN
UroGen Pharma management to meet with Oppenheimer
Premium
The Fly
UroGen Pharma management to meet with Oppenheimer
4M ago
URGN
UroGen Pharma initiated with a Buy at Guggenheim
PremiumThe Fly
UroGen Pharma initiated with a Buy at Guggenheim
5M ago
URGN
UroGen Pharma completes NDA submission for UGN-102
PremiumThe Fly
UroGen Pharma completes NDA submission for UGN-102
5M ago
URGN
UroGen Pharma says ahead of schedule to complete UGN-102 NDA
PremiumThe Fly
UroGen Pharma says ahead of schedule to complete UGN-102 NDA
5M ago
URGN
UroGen Pharma reports Q2 EPS (91c), consensus (83c)
PremiumThe Fly
UroGen Pharma reports Q2 EPS (91c), consensus (83c)
5M ago
URGN
Is URGN a Buy, Before Earnings?
PremiumPre-EarningsIs URGN a Buy, Before Earnings?
5M ago
URGN
UroGen Pharma Shareholders Shape Governance and Incentives
Premium
Company Announcements
UroGen Pharma Shareholders Shape Governance and Incentives
5M ago
8K
URGN
UroGen Pharma 5M share Spot Secondary priced at $17.50
Premium
The Fly
UroGen Pharma 5M share Spot Secondary priced at $17.50
7M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >